Multiple Sclerosis Walking Scale (MSWS-12): changes on all items are not equal

被引：0
|
作者：
Hobart, J. [1 ]
机构：
[1] Peninsula Coll Med & Dent, Plymouth, Devon, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P245
引用
收藏
页码：S92 / S93
页数：2
相关论文
共 50 条
  • [21] Responses to items of the MSWS-12 differ depending on EDSS and the impact of prolonged-release fampridine on walking speed
    McGuigan, C.
    Schapiro, R.
    Putzki, N.
    Hobart, J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S473 - S474
  • [22] The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory
    Matthew M. Engelhard
    Karen M. Schmidt
    Casey E. Engel
    J. Nicholas Brenton
    Stephen D. Patek
    Myla D. Goldman
    Quality of Life Research, 2016, 25 : 3221 - 3230
  • [23] The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory
    Engelhard, Matthew M.
    Schmidt, Karen M.
    Engel, Casey E.
    Brenton, J. Nicholas
    Patek, Stephen D.
    Goldman, Myla D.
    QUALITY OF LIFE RESEARCH, 2016, 25 (12) : 3221 - 3230
  • [24] Multiple Sclerosis and the Twelve Item MS Walking Scale (MSWS-12): The Relationship of the Patient Perspective to the 25 Foot Timed Walk and Multi-Dimensional Quantitative Gait Measures
    Baek, S.
    Kaczmarek, O.
    Bumstead, B.
    Buhse, M.
    Trebing, S.
    Zarif, M.
    Gudesblatt, M.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 43 - 44
  • [25] Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort
    Sidovar, Matthew F.
    Limone, Brendan L.
    Coleman, Craig I.
    PATIENT-RELATED OUTCOME MEASURES, 2016, 7 : 13 - 18
  • [26] Multiple Sclerosis Walking Scale-12 and oxygen cost of walking
    Motl, Robert W.
    Dlugonski, Deirdre
    Suh, Yoojin
    Weikert, Madeline
    Agiovlasitis, Stamatis
    Fernhall, Bo
    Goldman, Myla
    GAIT & POSTURE, 2010, 31 (04) : 506 - 510
  • [27] Evaluation of the effect of Autologous Hematopoietic Stem Cell Transplant on symptom severity using MSWS-12, ARMSQ and SymptoMScreen in multiple sclerosis patients
    Cruz-Perez, Gloria
    Gazca, Juan Carlos Olivares
    Garcia-Velez, Danae
    Melgar-de-la-Paz, Miranda
    Negrete-Rodriguez, Paola
    Hamilton-Aviles, Luis
    Olivares-Gazca, Juan
    Ruiz-Delgado, Guillermo
    Ruiz-Arguelles, Guillermo
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 738 - 738
  • [28] Clinical use of wearable inertial sensors to assess spatial-temporal parameters of gait in people with multiple sclerosis: correlation with MSWS-12
    Caggiari, S.
    Mura, A.
    Leban, B.
    Corona, F.
    Coghe, G.
    Marrosu, M. G.
    Cocco, E.
    Pau, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 132 - 132
  • [29] Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients
    Brendan L Limone
    Matthew F Sidovar
    Craig I Coleman
    Health and Quality of Life Outcomes, 11
  • [30] Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients
    Limone, Brendan L.
    Sidovar, Matthew F.
    Coleman, Craig I.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
12345